Sorin Group announced CE mark certification for its new MEMO 3D ReChord mitral valve annuloplasty ring that is now commercially available in Europe. The first implant was presented at the 28th Annual Meeting of the European Association for Cardiothoracic Surgery (EACTS) by Mattia Glauber.
MEMO 3D ReChord is the latest innovation from Sorin Group that offers a portfolio of solutions for all types of mitral valve disease. According to a press release, it is the ultimate repair device designed to deliver better patient outcomes while facilitating the surgical procedure. MEMO 3D ReChord features an innovative chordal guiding system, making artificial chordae tendineae replacement a routine and standardised procedure. Unique design elements include a carbofilm coating and laser cut Ni-Ti technology for truly physiologic performance.
Glauber, who presented the first implantation of the ring at the EACTS techno-college session, commented on the technology’s ease of use: “The MEMO 3D ReChord is very easy to place, and the chordal system is indeed very useful, especially in minimally invasive surgery. I have tried it in both anterior and posterior prolapse cases, and it worked nicely in both situations without the need for further adjustments. Of course, we need to gain more experience to be able to guide surgeons to the correct indication, but this first experience was extremely positive.
“In my opinion, this device has the potential to change the approach to mitral valve repair. We are facing a situation where we are resecting less and less while using more artificial chords; therefore, a system that helps to standardise artificial chord replacement is very timely,” continues Glauber.
